Clinical Research Directory
Browse clinical research sites, groups, and studies.
Pharmacogenetics of Antidepressant-Induced Disinhibition
Sponsor: University of Calgary
Summary
The purpose of this study is to identify pharmacogenetic profiles associated with selective serotonin reuptake inhibitors (SSRI)-induced behavioral disinhibition in children with Major depressive disorder (MDD), anxiety disorders and/or obsessive-compulsive disorder (OCD) that could be used clinically to reduce the incidence of this adverse event and improve health outcomes.
Official title: Pharmacogenetics of Antidepressant-Induced Disinhibition in Children Study
Key Details
Gender
All
Age Range
6 Years - 17 Years
Study Type
OBSERVATIONAL
Enrollment
120
Start Date
2019-01-02
Completion Date
2025-06-30
Last Updated
2024-05-09
Healthy Volunteers
No
Conditions
Locations (1)
Child and Adolescent Addiction, Mental Health & Psychiatry
Calgary, Alberta, Canada